Robert Charles Gallo
Affiliations: | Institute of Human Virology | University of Maryland, College Park, College Park, MD |
Area:
Virology, retroviruses, HIVWebsite:
http://www.ihv.org/about/bios/gallo.htmlGoogle:
"Robert Gallo"Bio:
http://www.science-connections.com/profiles/gallo/robertgallo.html#Honorary+Doctorate+Hamburg+2004
Born 1937. American discoverer of HTLV and co-discoverer of the human immunodeficiency virus although he was embroiled in a controversy with 2 French scientists over the precedence in the identification of HIV. The 2 French scientists were awarded the Nobel Prize for the discovery.
Children
Sign in to add trainee| Flossie Wong-Staal | post-doc | NCI, NIH (Microtree) | |
| Riccardo Dalla-Favera | post-doc | 1978-1982 | National Cancer Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gallo R, Buanec H, Schiavon V, et al. (2023) IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy. Research Square |
| Benedetti F, Snyder GA, Giovanetti M, et al. (2020) Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1. Journal of Translational Medicine. 18: 329 |
| Gallo RC. (2020) HIV/AIDS Research for the Future. Cell Host & Microbe. 27: 499-501 |
| Benedetti F, Cocchi F, Latinovic OS, et al. (2020) Role of Mycoplasma Chaperone DnaK in Cellular Transformation. International Journal of Molecular Sciences. 21 |
| Stafford KA, Mayer BT, Fulp W, et al. (2020) Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Tagaya Y, Matsuoka M, Gallo R. (2019) 40 years of the human T-cell leukemia virus: past, present, and future. F1000research. 8 |
| Sui Y, Lewis GK, Wang Y, et al. (2019) Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. The Journal of Clinical Investigation |
| Wu L, Zhang H, Jiang Y, et al. (2018) Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Proceedings of the National Academy of Sciences of the United States of America |
| Wu L, Zhang H, Jiang Y, et al. (2018) B-106 Development of anti-tumor cytotoxic lymphocytes using engineered human primary blood dendritic cells Journal of Acquired Immune Deficiency Syndromes. 77: 37 |
| Mengistu M, Tang AH, Foulke JS, et al. (2017) Patterns of conserved gp120 epitope presentation on attached HIV-1 virions. Proceedings of the National Academy of Sciences of the United States of America |